PAR 6.98% 20.0¢ paradigm biopharmaceuticals limited..

PAR & Chrons Disease, page-9

  1. 4,355 Posts.
    lightbulb Created with Sketch. 6897
    Sammyall, yes not quite sure why you started another thread based on this topic, Im guessing it was an error.

    Mate, no where in the original article on Chrons did I post that PAR WERE or ARE looking into it.
    I simply stated that it is another potential inflammatory condition that COULD POSSIBLY ONE DAY be looked at by PAR and its wonderful PPS compound.

    Sure Im glad you are researching into it. I also agree that this is a forum to discuss such topics and points of view. No point in simply up-ramping or down-ramping for the sake of it. Better to hear any potential hurdles rather than just concentrate on positives.

    https://hotcopper.com.au/data/attachments/1645/1645904-0b495fe9c51858f023d5c21d403025f8.jpg

 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.